Insulet Corporation
PODD
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 3 days ago • PODD
Here's Why Insulet (PODD) is a Strong Growth Stock
Business Wire • 3 days ago • PODD
Insulet Announces FDA 510(k) Clearance of OmnipodĀ® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
Seeking Alpha • 11 days ago • PODD
Artisan International Small-Mid Fund Q3 2025 Contrarianism Pays Off
Zacks Investment Research • 13 days ago • PODD
Looking for a Growth Stock? 3 Reasons Why Insulet (PODD) is a Solid Choice
Seeking Alpha • 16 days ago • PODD
Insulet Corporation (PODD) Analyst/Investor Day Transcript
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.